亚临床甲减与多囊卵巢综合征的相关性研究进展

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (676 KB) HTML (0 KB)
输出: BibTeX | EndNote (RIS)

摘要多囊卵巢综合征(PCOS)是一种导致育龄期女性生殖内分泌紊乱的疾病,PCOS常与代谢异常如血脂异常、胰岛素抵抗、2型糖尿病及其他代谢综合征有关,长期研究发现PCOS能增加心血管等疾病的远期发病风险。亚临床甲状腺功能减退症(SCH)是轻度的甲状腺功能紊乱,但亦能干扰女性正常的内分泌代谢功能。研究发现10％~25%的PCOS患者伴有SCH,但是迄今为止,尚不清楚SCH是否会加重PCOS女性的内分泌代谢紊乱程度和激素改变的严重程度,SCH与PCOS的相关性亦不明确。为了理清SCH在PCOS中所扮演的角色及其进一步诊治方法,本文就近几年SCH与PCOS相关性的研究进展进行综述。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	曹现岭
	孙振高

关键词 ：多囊卵巢综合征, 亚临床甲减, 相关性, 内分泌

收稿日期: 2019-10-21

基金资助:国家自然科学基金(81674018)

通讯作者: 孙振高(sunzhengao77@163.com)

引用本文:

曹现岭, 孙振高. 亚临床甲减与多囊卵巢综合征的相关性研究进展[J]. 中国生育健康杂志, 2021, 32(5): 486-489.

链接本文:

http://cjrh.bjmu.edu.cn/CN/ 或 http://cjrh.bjmu.edu.cn/CN/Y2021/V32/I5/486

1 Goldrat O,Delbaere A.PCOS:update and diagnostic approach.Clin Biochem,2018,62:24-31.
2 Ding XH,Yang LL,Wang J,et al.Subclinical hypothyroidism in polycystic ovary syndrome:a systematic review and meta-analysis.front endocrinol (lausanne),2018,9:700.
3 Fitzgerald S,Divasta A,Gooding H.An update on PCOS in adolescents.Curr Opin Pediatr,2018,30:459-465.
4 Bozdag G,Mumusoglu S,Zengin D,et al.The prevalence and phenotypic features of polycystic ovary syndrome:a systematic review and meta-analysis.Human Reprod,2016,31:2841-2855.
5 de Medeiros SF,Barbosa JS Yamamoto MMW.Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women.J Obstet Gynaecol Res,2014,41:254-263.
6 Teng W,Shan Z,Patil-Sisodia K,et al.Hypothyroidismin pregnancy.Lancet Diabetes Endocrinol,2013,1:228-237.
7 Ramanand S,Ramanand J,Ghanghas R,et al.Clinical characteristics of polycystic ovary syndrome in Indian women.Indian J Endocrinol Metab,2013,17:138.
8 Singla R,Gupta Y,Khemani M,et al.Thyroid disorders and polycystic ovary syndrome:An emerging relationship.Indian J Endocrinol Metab,2015,19:25-29.
9 Hennessey JV,Espaillat R.Diagnosis and management of subclinical hypothyroidism in elderly adults:a review of the literature.J Am Geriatr Soc,2015,63:1663-1673.
10 Han C,He X,Xia X,et al.Subclinical hypothyroidism and type 2 diabetes:a systematic review and meta-analysis.PLoS One,2015,10:1-22.
11 Fatourechi V.Subclinical hypothyroidism:an update for primary care physicians.Mayo Clinic Proc,2009,84 :65-71.
12 Practice committee of the american society for reproductive medicine.Subclinical hypothyroidism in the infertile female population:a guideline.Fertility and Sterility,2015,104:545-553.
13 Pergialiotis V,Konstantopoulos P,Prodromidou A.et al.Management of endocrine disease:the impact of subclinical hypothyroidism on anthropometric characteristics,lipid,glucose and hormonal profile of PCOS patients:a systematic review and meta-analysis.Europ J Endocrinol,2017,176:R159-R166.
14 Yu Q,Wang JB.Subclinical hypothyroidism in POCS:impact on presentation,insulin resistance,and cardiovascular risk.BioMed Res Int,2016,2016:1-7.
15 Zhang B,Wang J,Shen S.et al.Subclinical hypothyroidism is not a risk factor for polycystic ovary syndrome in obese women of reproductive age.Gynecol Endocrinol,2018,34:1-5.
16 Platt AM.Insulin resistance,metabolic syndrome,and polycystic ovary syndrome in obese youth.NASN Sch Nurse,2015,30:207-213.
17 Walters KA,Handelsman DJ.Role of androgens in the ovary.Mol Cell Endocrinol,2018,465:36-47.
18 Bedaiwy MA,Abdel-Rahman MY,Justin T,et al.Clinical,Hormonal,and metabolic parameters in women with subclinical hypothyroidism and polycystic ovary syndrome:a cross-sectional study.J Womens Health (Larchmt),2018,27:659-664.
19 Ganie MA,Laway BA,Wani TA.et al.Association of subclinical hypothyroidism and phenotype,insulin resistance,and lipid parameters in young women with polycystic ovary syndrome.Fertil Steril,2011,95:2039-2043.
20 Karakaya BK,Ozgu E,Kansu HC,et al.Thyroid-stimulating hormone and insulin resistance:their association with polycystic ovary syndrome without overt hypothyroidism.Rev Bras Ginecol Obstet,2017,39:224-228.
21 Muscogiuri G,Sorice GP,Mezza T,et al.High-normal tsh values in obesity:Is it insulin resistance or adipose tissues guilt?.Obesity,2013,21:101-106.
22 Maratou E,Hadjidakis DJ,Kollias A,et al.Studies of insulin resistance in patients with clinical and subclinical hypothyroidism.Europ J Endocrinol,2009,160:785-790.
23 Enzevaei A,Salehpour S,Tohidi M.et al.Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome:is there a relationship?.Iranian J Reprod Med,2014,12:481.
24 Tagliaferri V,Romualdi D,Guido Ma.et al.The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight:an euglycaemic-hyperinsulinaemic clamp study.Eur J Endocrinol,2016,175:433-441.
25 De-Medeiros S,De-Medeiros M,Ormond C.et al.Subclinical hypothyroidism impact on the characteristics of patients with polycystic ovary syndrome.a meta-analysis of observational studies.Gynecol Obstet Invest,2018,83:105-115.
26 Rotondi M,Cappelli C,Magri F,et al.Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome.Clinic endocrinol,2011,75:378-381.
27 Marciniak A,Nawrocka RJ,Brodowska A,et al.Cardiovascular system diseases in patients with polycystic ovary syndrome-the role of inflammation process in this pathology and possibility of early diagnosis and prevention.Ann Agric Environ Med,2016,23:537-541.
28 Rizos CV,Elisaf MS,Liberopoulos EN.Effects of thyroid dysfunction on lipid profile.Open Cardiovasc Med J,2011,5:76-84.
29 Romitti M,Fabris VC,Ziegelmann PK.et al.Association between PCOS and autoimmune thyroid disease:a systematic review and meta-analysis.Endocr Connect,2018,7:1158-1167.
30 Nezi M,Christopoulos P,Paltoglou G.et al.Focus on BMI and subclinical hypothyroidism in adolescent girls first examined for amenorrhea or oligomenorrhea.The emerging role of polycystic ovary syndrome.Pediatr Endocrinol Metab,2016,29:693-702.
31 Reinehr T,Isa A,De SG.et al.Thyroid hormones and their relation to weight status.Horm Res Paediat,2008,70:51-57.
32 Huang R,Zheng J,Li S.et al.Subclinical hypothyroidism in patients with polycystic ovary syndrome:distribution and its association with lipid profiles.Eur J Obstet Gynecol Reprod Biol 2014,177:52-56.
33 Lu YH,Xia ZL,Ma YY,et al.Subclinical hypothyroidism is associated with metabolic syndrome and clomiphene citrate resistance in women with polycystic ovary syndrome.Gynecol Endocrinol,2016,32:852-855.
34 Dittrich R,Kajaia N,Cupisti S,et al.Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS.Reprod Biomed Online,2009,19:319-325.
35 Velkeniers B,Van Meerhaeghe A,Poppe K,et al.Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies:systematic review and meta-analysis of RCTs.Hum Reprod Update,2013,19:251-258.
36 Novais JDSM,Benetti-Pinto CL,Garmes HM,et al.Polycystic ovary syndrome and chronic autoimmune thyroiditis.Gynecol Endocrinol,2015,31;48-51.
37 De-Medeiros SF,Mmw Y,Mas DM.et al.Should subclinical hypothyroidism be an exclusion criterion for the diagnosis of polycystic ovary syndrome?.J Reprod Infertil,2017,18:242-250.
38 Yue FZ,Zhang DM,Gong F,et al.Subclinical hypothyroidism and endocrine metabolic characteristics in women with polycystic ovary syndrome.Zhong Nan Da Xue Xue Bao Yi Xue Ban,2017,42:940-946.
39 Trakakis E,Pergialiotis V,Hatziagelaki E,et al.Subclinical hypothyroidism does not influence the metabolic and hormonal profile of women with PCOS.Horm Mol Biol Clin Investig,2017,31:undefined.